Antheia and Olon Group extend partnership to leverage Olon's fermentation infrastructure for Antheia's early products.

Antheia, a pharmaceutical ingredient manufacturer, and Olon Group, an API manufacturing leader, continue their partnership to leverage Olon's fermentation infrastructure to produce Antheia's early products, including Biosynthetic KSMs and APIs. Established in 2022, the partnership allows Olon to support Antheia's scale-up and commercialization efforts, with a focus on meeting international demand for essential medicines.